Generation of a TIMP3 knockout stem cell line via CRISPR/Cas9 system

Stem Cell Res. 2023 Mar:67:103034. doi: 10.1016/j.scr.2023.103034. Epub 2023 Jan 24.

Abstract

The tissue inhibitors of metalloproteinases 3 (TIMP3) play an essential role in the tumorigenesis of human pancreatic endocrine tumors and Sorsby fundus dystrophy. To further investigate the significance of TIMP3 in disease, we used CRISPR/Cas9 to create a TIMP3 knock out human embryonic stem cell line (WAe009-A-89) that can differentiate into any desired cell type. Our results show that the WAe009-A-89 cell line retains the typical colony form and normal karyotype of stem cells. The cells strongly expressed pluripotency markers and could differentiate into tissues of all three germ layers in vivo. This cell line allowed exploring the role of the TIMP3 gene in related diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Cas Systems
  • Cell Line
  • Embryonic Stem Cells / metabolism
  • Human Embryonic Stem Cells* / metabolism
  • Humans
  • Macular Degeneration* / genetics
  • Tissue Inhibitor of Metalloproteinase-3 / genetics
  • Tissue Inhibitor of Metalloproteinase-3 / metabolism

Substances

  • TIMP3 protein, human
  • Tissue Inhibitor of Metalloproteinase-3